To induce tolerance for gluten in genetically predisposed children for coeliac disease through the introduction of small quantities of gluten during the period of breast-feeding.
ID
Bron
Verkorte titel
Aandoening
coeliac disease (coeliakie); gluten; prevention (prevensie); breastfeeding (borstvoeding); early feeding (baby voeding); genetic predisposition (genetisch predispositie); HLA; food intervention (voedings interventie); prospective (prospectief); double blind; randomized (gerandomiseerd), multicenter; European (Europesse); EU FP6.
Ondersteuning
It's a Sixth Framework project.
In total is the financial support: 3.675.000,-
Divided over 2 studies; the family study and the population study.
The intervention family study has: 2.992.347,-euro
(and population study: 682.653,-euro)
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
A reduction of 50% of CD among the intervention group at the age of 3 years will be considered as an effective prevention.
Achtergrond van het onderzoek
Title of the study:
Influence of the dietary history in the prevention of coeliac disease : possibilities of induction of tolerance for gluten in genetically predisposed children.
Background of the study:
Coeliac disease (CD) is a chronic disorder caused by hypersensitivity to some of the most common proteins (gluten) in the diet of the European population. CD affects as much as 1% of the Europeans (2.5 million people) and is the most common food intolerance in Europe. If recognised, CD patients have only limited access to safe foods and there is not causal therapy available. The proposed study is a multicenter European project PREVENTCD, founded by the European Commission FP-6-2005-FOOD-4B; Proposal/Contract no.: 036383.
The general objective of PREVENTCD is to significantly reduce the number of people suffering from CD in Europe, by developing primary prevention strategies for CD.
The hypothesis of the study is that it is possible to induce tolerance for gluten in genetically predisposed children through the introduction of small quantities of gluten during the period of breast-feeding.
Objective of the study:
1. Development of a prevention strategy for CD in children from high risk families for the disease by induction of oral tolerance to gluten;
2. Identification of the immunological mechanisms involved in initiating the aberrant response to gluten introduction in the diet of infants genetically predisposed to CD;
3. Identification of the factors in the early dietary history involved in the aberrant response to gluten in children;
Study design:
European, multicenter, double blind, prospective, randomised food intervention study
Study population:
1000 infants born from families with one parent or sibling with diagnosed CD.
Intervention:
The children bearing HLA-DQ2 and/or DQ8 will be blindly randomised to either a group for "tolerance induction for gluten" or to a "control" group. At least 6 months of breast-feeding will be STRONGLY encouraged for all the children.
At the age of 4 months tolerance induction will be attempted by the daily intake of 1g wheat flour (100 mg gluten) during 8 weeks while continuing breast-feeding. No gluten will be given in these 8 weeks to control infants, but 1g. lactose as a placebo intervention.
primair outcome:
A reduction of 50% of CD among the intervention group at the age of 3 years will be considered as an effective prevention.
Secondary outcome:
- If the proposed early dietary intervention results in effective prevention of CD: development of new European guidelines for early nutrition in order to prevent the disease.
- Identification of the influence of early feeding on the development of coeliac disease in relation with immunological and genetical factors.
Doel van het onderzoek
To induce tolerance for gluten in genetically predisposed children for coeliac disease through the introduction of small quantities of gluten during the period of breast-feeding.
Onderzoeksopzet
-
Onderzoeksproduct en/of interventie
In the family study:
1. The ‘intervention group’ will get a small amount of gluten (1 gram of wheat flour= 100mg gliadin) during the period of breastfeeding from the age of 4 months for 8 weeks.
2. The ‘control group' (placebo) will get milk sugar powder (1gram of lactose) during the period of breastfeeding from the age of 4 months for 8 weeks.
Publiek
Dept. Of Pediatrics
PO box 9600
M.L. Mearin
Leiden 2300 RC
The Netherlands
-
M.L.Mearin_Manrique@lumc.nl
Wetenschappelijk
Dept. Of Pediatrics
PO box 9600
M.L. Mearin
Leiden 2300 RC
The Netherlands
-
M.L.Mearin_Manrique@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1.Infant born during the study with a first degree relative (parent or sibling) with CD;
2.Informed consent for the study.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. No informed consent;
2. Parents-guardians unable to understand the information necessary to give informed consent.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL876 |
NTR-old | NTR890 |
Ander register | - : N/A |
ISRCTN | ISRCTN74582487 |
Samenvatting resultaten
http://preventcd.com/images/stories/Publications/PreventCD_SAP_1_0.pdf